Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Solventum Corporation (SOLV:NYSE), powered by AI.
Solventum Corporation is currently trading at $78.87. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Solventum Corporation on Alpha Lenz.
Solventum Corporation's P/E ratio is 8.8.
“Solventum Corporation trades at a P/E of 8.8 (undervalued) with strong ROE of 38.9%.”
Ask for details →Solventum Corporation is a leading American healthcare company that emerged as an independent entity following its spin-off from 3M in April 2024. Built on over 70 years of healthcare innovation, Solventum develops, manufactures, and commercializes solutions aimed at addressing critical needs in the global medical community. The company's operations encompass four primary segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Solventum's products and services support a diverse array of healthcare applications, from advanced medical and surgical equipment to digital dental solutions and health information systems, impacting both providers and patients. With a workforce exceeding 20,000 professionals and a presence in 38 countries, Solventum operates more than 300 offices and facilities worldwide. The corporation has established itself as a significant force in the global healthcare sector, consistently advancing new technologies and fostering partnerships to improve health outcomes. Solventum emphasizes sustainability, innovation, and addressing healthcare disparities, aiming to create a healthier future. Its substantial scale and diversified healthcare portfolio position it as a critical player in shaping industry standards and supporting the delivery of effective, safer patient care across international markets.
“Solventum Corporation trades at a P/E of 8.8 (undervalued) with strong ROE of 38.9%.”
Ask for details →Solventum Corporation (ticker: SOLV) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 22,000 employees. Market cap is $13.7B.
The current price is $78.87 with a P/E ratio of 8.82x and P/B of 2.72x.
ROE is 38.86% and operating margin is 7.59%. Annual revenue is $8.3B.